C.R. Bard

red blood cells
MedTech

ACC: Study finds no increased death risk with paclitaxel devices

An audit of nearly four years of Medicare data spanning more than 168,000 beneficiaries found no evidence of additional harm.
Conor Hale May 16, 2021 5:30pm
Empty boardroom

Stryker makes offer to take over Boston Scientific, report says

Jun 12, 2018 1:55pm
fda

FDA OKs Bard’s Lutonix drug-coated balloon for renal disease complication

Aug 28, 2017 12:14pm
The Federal Trade Commission in Washington DC

Trade watchdog demands more information from BD, Bard

Jun 12, 2017 9:59am
Handshake

BD pens $24B Bard buyout to create medtech powerhouse

Apr 24, 2017 3:12am